IRINA M LYTVYN

Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Adult Health PORT RICHEY, FL NPI 1114358538

General Payments — all program years on this page

$4,092.49

  • Category: General Payments
  • Program years: PY2021–2024
  • Record count: 52
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $758.62 across 19 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $758.6219

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
MERZ NORTH AMERICA, INC. $270.206
ABBVIE INC. $240.685
Galderma Laboratories, L.P. $170.537
REVANCE THERAPEUTICS, INC. $77.211

By program year

Program yearAmountRecords
2021 $160.104
2022 $508.339
2023 $2,665.4420
2024 $758.6219

Records — PY2024 (19)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1107570754 ABBVIE INC. $150.00 05/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107570756 ABBVIE INC. $33.77 06/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107570758 ABBVIE INC. $10.25 06/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107570760 ABBVIE INC. $22.67 09/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107570762 ABBVIE INC. $23.99 11/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145372647 Galderma Laboratories, L.P. $26.65 04/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145372649 Galderma Laboratories, L.P. $4.87 04/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145372651 Galderma Laboratories, L.P. $17.14 07/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145372653 Galderma Laboratories, L.P. $99.47 08/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145372655 Galderma Laboratories, L.P. $7.78 08/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145372657 Galderma Laboratories, L.P. $12.08 11/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145372659 Galderma Laboratories, L.P. $2.54 11/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1146383833 MERZ NORTH AMERICA, INC. $23.20 01/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1146383835 MERZ NORTH AMERICA, INC. $24.10 02/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1146383837 MERZ NORTH AMERICA, INC. $14.48 03/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1146383839 MERZ NORTH AMERICA, INC. $176.75 02/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1146383841 MERZ NORTH AMERICA, INC. $15.06 05/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1146383843 MERZ NORTH AMERICA, INC. $16.61 05/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147945384 REVANCE THERAPEUTICS, INC. $77.21 10/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.